CytoDyn Announces FDA Accepts Revised Rolling Review Timeline for Resubmission of its BLA | CYDY Message Board Posts




  • We have set up a new board (#AdminHowTo) to better assist you with using our service and getting the most out of it.

    To access the board, click the blue link above or, if you are a registered member, you can check the latest message from Admin in your IV Inbox and click the link provided there as well.  

CYDY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board
Msg  12500 of 12964  at  10/28/2021 8:56:32 AM  by

jakeflies


 In response to msg 12497 by  DonPA
view thread

Re: CytoDyn Announces FDA Accepts Revised Rolling Review Timeline for Resubmission of its BLA

 "Clawback" in this case would be the return of any shares execs received as a result of  the submission of the "supposed completed" BLA submission.. (plus any penalties)..  
[I believe Team was awarded significant amount of shares for the "submission" which they may have subsequently sold..] 


     e-mail to a friend      printer-friendly     add to library      
|  
Recs: 4  
   Views: 0 []
Previous Message  Next Message    Post Message    Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
12520 Re: CytoDyn Announces FDA Accepts Revised Rolling Review Timeline for Resubmission of its BLA DonPA 0 10/28/2021 1:14:57 PM


Financial Market Data provided by
.
Loading...